INSP Dec 2024 200.000 call
| Previous close | 7.70 |
| Open | 7.70 |
| Bid | 3.70 |
| Ask | 7.50 |
| Strike | 200.00 |
| Expiry date | 2024-12-20 |
| Day's range | 7.70 - 7.70 |
| Contract range | N/A |
| Volume | |
| Open interest | 204 |
GlobeNewswireInspire Medical Systems, Inc. Announces Countrywide Reimbursement in France
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today the publication of the reimbursement of Inspire therapy in France. “We are thrilled to offer our clinically proven treatment option for moderate to severe OSA to patients and physicians in France,” said Tim Herbe
ZacksInspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
Inspire Medical's (INSP) receipt of the latest CE mark certification will likely enable it to continue to deliver Inspire products globally.
Insider MonkeyIs This The Right Entry Point To Add Inspire Medical Systems (INSP)?
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund declined 1.06% outperforming a 3.28% decline for the Russell 2000 Index and a 4.27% decline for the Russell 2500 Index. In the second quarter, the small-cap […]
